Dr Alexander Mathioudakis, BRC Clinical Fellow discusses how the TRACE-COPD trial is using blood tests to guide and target the administration of antibiotics at Wythenshawe Hospital.
A new clinical study at Wythenshawe Hospital, aims to develop a technique which will identify young women, aged 30 – 45, at increased risk of breast cancer.
A newly launched radiotherapy study, involving cervical cancer patients, is the first in Manchester to simultaneously combine two different examinations techniques: PET-MR with tracer administration.
Stephanie Yau, Rare Disease Project Manager, blogs about the importance of rare disease research and work underway to bring together rare disease cohorts across MFT.
The 1st in a series organised by the Cellular and developmental systems (CDS) research domain to encourage discussion and collaboration in the area of cell disease and developmental abnormalities.